The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| AIDS Education and Training Center National Clinician Consultation Center |
93.145 |
HRSA-20-072 |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional) |
93.273 |
RFA-AA-20-011 |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional) |
93.273 |
RFA-AA-20-012 |
| New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) |
93.113, 93.393, 93.399 |
RFA-CA-20-049 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
93.394 |
PAR-20-313 |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) |
93.394 |
PAR-20-314 |
| Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-20-018 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
93.879 |
PAR-21-046 |
| New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed) |
93.113, 93.393, 93.399 |
RFA-CA-20-050 |
| Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional) |
93.273 |
RFA-AA-20-013 |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
93.113, 93.172, 93.233, 93.242, 93.273, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.866, 93.867, 93.879, 93.989 |
PA-20-272 |
| National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional) |
93.121 |
PAR-20-306 |
| AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
93.242 |
PAR-20-308 |
| Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-056 |
| Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
93.242 |
PAR-20-307 |
| Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
93.846 |
PAR-21-030 |
| A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-064 |
| MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-027 |
| Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) |
93.865 |
RFA-HD-21-030 |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
93.113 |
PA-20-275 |
| Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-21-027 |
| Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-057 |
| Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
93.279 |
PAR-21-044 |
| Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-060 |
| Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) |
93.273, 93.279, 93.307, 93.313 |
PAR-20-310 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) |
93.121, 93.395 |
PAR-20-305 |
| Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed) |
93.242, 93.279, 93.853 |
RFA-MH-20-701 |
| Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed) |
93.242, 93.279, 93.853 |
RFA-MH-20-702 |
| Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for the NIDDK Gastroparesis Consortium (U24 Clinical Trial Optional) |
93.847 |
RFA-DK-20-505 |
| Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-21-018 |
| Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional) |
93.847 |
RFA-DK-20-504 |
| Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-20-055 |
| BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-20-620 |
| Pediatric and Reproductive Environmental Health Scholars (PREHS): Strengthening the Pipeline (K12 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-20-007 |
| Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-20-046 |
| Limited Competition for Continuation of the Integrated Islet Distribution Program (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-509 |
| Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed) |
93.173 |
RFA-DC-20-002 |
| Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-20-043 |
| Drug Development Collaboratory (UG3/UH3 Clinical Trial Required) |
93.350 |
PAR-20-301 |
| Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (UG3/UH3 Clinical Trial Required) |
93.350 |
RFA-TR-20-031 |
Search Results 1-40 of 12062
Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 [Next] |
